Related Experiment Video
Updated: May 16, 2025

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
Published on: December 15, 2014
IL-36RN gene: key insights into its role in pediatric pustular psoriasis pathogenesis and treatment
Ye Wang1, Mingyue Li2, Changcheng Hou3
1School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Insights
Pediatric pustular psoriasis (PPP) is linked to the Interleukin-36 Receptor Antagonist (IL-36RN) gene. Research on IL-36RN
Area of Science:
- Dermatology
- Genetics
- Immunology
Background:
- Pediatric pustular psoriasis (PPP) is a severe autoimmune skin condition impacting children's well-being.
- The Interleukin-36 Receptor Antagonist (IL-36RN) gene is crucial in PPP development.
Purpose of the Study:
- To review current research on the IL-36RN gene in PPP pathogenesis and treatment.
- To consolidate information on IL-36RN structure, function, mutations, and inheritance.
- To examine IL-36RN mutation frequency and treatment strategies for different PPP types.
Main Methods:
- Comprehensive literature review of studies on IL-36RN and PPP.
- Analysis of gene structure, function, mutation types, and inheritance patterns.
- Evaluation of mutation frequencies and treatment outcomes in PPP patients.
Main Results:
- The IL-36RN gene's role in PPP pathogenesis is well-established.
- Specific IL-36RN mutations are associated with various PPP subtypes.
- Treatment strategies are being developed based on understanding IL-36RN's function.
Conclusions:
- IL-36RN is a key factor in pediatric pustular psoriasis.
- Further research into IL-36RN mutations can guide personalized treatment approaches.
- This review provides a foundation for advancing PPP research and therapy.
Abstract:
Pediatric pustular psoriasis (PPP) is an autoimmune skin disease that seriously affects the physical and mental health of children. The IL-36RN (Interleukin-36 Receptor Antagonist) gene plays a key role in the pathogenesis of PPP. This review comprehensively elaborates on the research progress of IL-36RN in the context of the pathogenesis and treatment of PPP, covering the basic structure, function, mutation sites and types, and inheritance patterns of the gene and its role in the pathogenesis of PPP. In addition, we discussed the frequency of IL-36RN mutations in patients with different types of PPP and the treatment methods for these patients, aiming to provide a valuable reference for further research and treatment of this disease.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
06:29Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 1, 2011
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway